Mark Jeffrey DeLong insider trades
Open-market stock purchases and sales by Mark Jeffrey DeLong, Chief Business & Strat Officer at Apellis Pharmaceuticals, Inc, from SEC Form 4 filings since May 18, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | — |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.6M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $205K |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $965K |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $831K |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.3M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $328K |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.6M |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold (not open market) | $1.6M |
| Feb 11, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $8.2K |
| Jan 28, 2026 | APLS Apellis Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 22, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $73.4K |
| Jan 20, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $26.4K |
| Jan 13, 2026 | APLS Apellis Pharmaceuticals, Inc | Sold | $39.5K |
Companies traded
- APLS Apellis Pharmaceuticals, Inc: 27 sales, last May 14, 2026
Get free alerts when Mark Jeffrey DeLong files a new trade →